Intrinsiqs

Is Integra LifeSciences Holdings Corporation overvalued?

Integra LifeSciences Holdings Corporation (IART) looks undervalued — trading about 342% below its fair value.

Undervalued
Current price $18.34 Fair value $81.11
Price
$18.34
Fair value
$81.11
Current P/E
7.8
Normal P/E
34.4
Market cap
$1.43B
Dividend yield
0.0%
Return on equity
-0.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares IART's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.